MiR-141 and MiR-200c As Markers of Overall Survival in Early Stage Non-small Cell Lung Cancer Adenocarcinoma

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 Jul 9

PMID 25003366

Citations 80

Authors

Rut Tejero

Alfons Navarro

Marc Campayo

Nuria Vinolas

Ramon M Marrades

Anna Cordeiro

Marc Ruiz-Martinez

Sandra Santasusagna

Laureano Molins

Josep Ramirez

Mariano Monzo

Affiliations

Soon will be listed here.

Abstract

Background: Several treatments in non-small cell lung cancer (NSCLC) are histology-dependent, and the need for histology-related markers is increasing. MicroRNAs (miRNAs) are promising molecular markers in multiple cancers and show differences in expression depending on histological subtype. The miRNA family miR-200 has been associated with the regulation of epithelial-mesenchymal (EMT)/mesenchymal-epithelial transition (MET). EMT involves profound phenotypic changes that include the loss of cell-cell adhesion, the loss of cell polarity, and the acquisition of migratory and invasive properties that facilitates metastasis. A dual role for the miR-200 family in the prognosis of several tumors has been related to tumor cell origin. However, the prognostic role and function of miR-200 family in early-stage NSCLC adenocarcinoma and squamous cell carcinoma (SCC) have not been well established.

Methods: miRNA expression was determined using TaqMan assays in 155 tumors from resected NSCLC patients. Functional studies were conducted in three NSCLC cell lines: H23, A-549 and HCC-44.

Results: High miR-200c expression was associated with shorter overall survival (OS) in the entire cohort (p = 0.024). High miR-200c (p = 0.0004) and miR-141 (p = 0.009) expression correlated with shorter OS in adenocarcinoma - but not in SCC. In the multivariate analysis, a risk score based on miR-141 and miR-200c expression emerged as an independent prognostic factor for OS in the entire cohort (OR, 2.787; p = 0.033) and in adenocarcinoma patients (OR, 10.649; p = 0.002). Functional analyses showed that miR-200c, was related to mesenchymal-epithelial transition (MET) and affected cell migration and E-cadherin levels, while overexpression of miR-141 reduced KLF6 protein levels and produced an increase of secretion of VEGFA in vitro (H23, p = 0.04; A-549, p = 0.03; HCC-44, p = 0.02) and was associated with higher blood microvessel density in patient tumor samples (p<0.001).

Conclusion: High miR-141 and miR-200c expression are associated with shorter OS in NSCLC patients with adenocarcinoma through MET and angiogenesis.

Citing Articles

Potential utility of miRNAs derived from pleural fluid extracellular vesicles to differentiate between benign and malignant pleural effusions.

Chee T, Zahra C, Fong K, Yang I, Bowman R Transl Lung Cancer Res. 2025; 14(1):124-138.

PMID: 39958230 PMC: 11826272. DOI: 10.21037/tlcr-24-945.

Role of Angiogenesis and Its Biomarkers in Development of Targeted Tumor Therapies.

Pathak A, Pal A, Roy S, Nandave M, Jain K Stem Cells Int. 2024; 2024:9077926.

PMID: 38213742 PMC: 10783989. DOI: 10.1155/2024/9077926.

Exploring the role of miR-200 family in regulating CX3CR1 and CXCR1 in lung adenocarcinoma tumor microenvironment: implications for therapeutic intervention.

Sharma A, Singh P, Jha R, Almatroodi S, Alrumaihi F, Rahmani A Sci Rep. 2023; 13(1):16333.

PMID: 37770496 PMC: 10539366. DOI: 10.1038/s41598-023-43484-1.

Biological functions and research progress of eIF4E.

Chen X, An Y, Tan M, Xie D, Liu L, Xu B Front Oncol. 2023; 13:1076855.

PMID: 37601696 PMC: 10435865. DOI: 10.3389/fonc.2023.1076855.

Interactions between circRNAs and miR-141 in Cancer: From Pathogenesis to Diagnosis and Therapy.

Guz M, Jeleniewicz W, Cybulski M Int J Mol Sci. 2023; 24(14).

PMID: 37511619 PMC: 10380543. DOI: 10.3390/ijms241411861.

References

Artells R, Navarro A, Diaz T, Monzo M . Ultrastructural and immunohistochemical analysis of intestinal myofibroblasts during the early organogenesis of the human small intestine. Anat Rec (Hoboken). 2011; 294(3):462-71. DOI: 10.1002/ar.21333. View

Gallardo E, Navarro A, Vinolas N, Marrades R, Diaz T, Gel B . miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis. 2009; 30(11):1903-9. DOI: 10.1093/carcin/bgp219. View

Campayo M, Navarro A, Vinolas N, Diaz T, Tejero R, Gimferrer J . Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer. Eur Respir J. 2012; 41(5):1172-8. DOI: 10.1183/09031936.00048712. View

Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. CA Cancer J Clin. 2012; 62(1):10-29. DOI: 10.3322/caac.20138. View

Hu X, Macdonald D, Huettner P, Feng Z, El Naqa I, Schwarz J . A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. Gynecol Oncol. 2009; 114(3):457-64. DOI: 10.1016/j.ygyno.2009.05.022. View

Valladares-Ayerbes M, Reboredo M, Medina-Villaamil V, Iglesias-Diaz P, Lorenzo-Patino M, Haz M . Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer. J Transl Med. 2012; 10:186. PMC: 3494541. DOI: 10.1186/1479-5876-10-186. View

Liu X, Zhu W, Huang Y, Ma L, Zhou S, Wang Y . High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol. 2011; 29(2):618-26. DOI: 10.1007/s12032-011-9923-y. View

Wang G, Guo X, Hong W, Liu Q, Wei T, Lu C . Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation. Proc Natl Acad Sci U S A. 2013; 110(8):2858-63. PMC: 3581874. DOI: 10.1073/pnas.1212769110. View

Bartel D . MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136(2):215-33. PMC: 3794896. DOI: 10.1016/j.cell.2009.01.002. View

10.

Gregory P, Bert A, Paterson E, Barry S, Tsykin A, Farshid G . The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008; 10(5):593-601. DOI: 10.1038/ncb1722. View

11.

Upton M, Hirohashi S, Tome Y, Miyazawa N, Suemasu K, Shimosato Y . Expression of vimentin in surgically resected adenocarcinomas and large cell carcinomas of lung. Am J Surg Pathol. 1986; 10(8):560-7. DOI: 10.1097/00000478-198608000-00006. View

12.

Uhlmann S, Zhang J, Schwager A, Mannsperger H, Riazalhosseini Y, Burmester S . miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene. 2010; 29(30):4297-306. DOI: 10.1038/onc.2010.201. View

13.

Pecot C, Rupaimoole R, Yang D, Akbani R, Ivan C, Lu C . Tumour angiogenesis regulation by the miR-200 family. Nat Commun. 2013; 4:2427. PMC: 3904438. DOI: 10.1038/ncomms3427. View

14.

DiFeo A, Narla G, Hirshfeld J, Camacho-Vanegas O, Narla J, Rose S . Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination. Clin Cancer Res. 2006; 12(12):3730-9. DOI: 10.1158/1078-0432.CCR-06-0054. View

15.

Korpal M, Ell B, Buffa F, Ibrahim T, Blanco M, Celia-Terrassa T . Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med. 2011; 17(9):1101-8. PMC: 3169707. DOI: 10.1038/nm.2401. View

16.

Bremnes R, Camps C, Sirera R . Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer. 2005; 51(2):143-58. DOI: 10.1016/j.lungcan.2005.09.005. View

17.

Ceppi P, Mudduluru G, Kumarswamy R, Rapa I, Scagliotti G, Papotti M . Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol Cancer Res. 2010; 8(9):1207-16. DOI: 10.1158/1541-7786.MCR-10-0052. View

18.

Brabletz T . To differentiate or not--routes towards metastasis. Nat Rev Cancer. 2012; 12(6):425-36. DOI: 10.1038/nrc3265. View

19.

Kawai T, Torikata C, Suzuki M . Immunohistochemical study of pulmonary adenocarcinoma. Am J Clin Pathol. 1988; 89(4):455-62. DOI: 10.1093/ajcp/89.4.455. View

20.

Roybal J, Zang Y, Ahn Y, Yang Y, Gibbons D, Baird B . miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. Mol Cancer Res. 2010; 9(1):25-35. PMC: 3232024. DOI: 10.1158/1541-7786.MCR-10-0497. View